Access to the PDF text

Free Article !

Archives of cardiovascular diseases
Volume 102, n° S1
page 37 (mars 2009)
Doi : 10.1016/S1875-2136(09)72214-4
Themes et posters

D004 Pharmacological blockade of angiotensin II type 2 receptor inhibits tumor growth decreasing cell proliferation and tumor vascularization

N. Clere 1, I. Corre 2, S. Faure 1, A.-L. Guihot 1, E. Vessieres 1, M. Chalopin 1, A. Morel 2, O. Coqueret 2, L. Hein 3, Y. Delneste 2, F. Paris 2, D. Henrion 1
1 UMR CNRS 6214 — Inserm U771, Angers, France 
2 Inserm U892, Nantes, France 
3 Institut für Experimentelle und Klinische Pharmakologie und Toxikologie, Freiburg, Germany 


Angiotensin II type 2 receptor (AT2R) stimulation is thought to induce vasodilation and apoptosis. Nevertheless, its role remains controversial. In hypertension and aging, AT2R might promote vasoconstriction and cell growth. In cancer cells, AT2R is highly expressed but its role remains poorly understood. Thus, we investigated the role of AT2R in tumor growth, hypothesizing that AT2R affects cell proliferation and/or tumor vascularization.

Tumor induction by 3-methylcholanthrene was significantly delayed in AT2R knockout mice, suggesting a role for AT2R in tumor initiation.

Tumor growth after subcutaneous injection of LL/2 cancer cells in C57/BL6 mice treated with PD123,319, an AT2R antagonist, was decreased when PD123,319 was given at an early stage, suggesting that AT2R is also involved in tumor promotion. In vitro proliferation of LL/2 cells was reduced by PD123,319 with a significant decrease in Ki67 expression and ERK1/2 phosphorylation. In addition, tumor vascular density, measured by CD31 labeling and angiogenesis using the aortic ring assay on Matrigel®, were reduced by PD123,319 and in AT2R-null mice. Therefore, we uncovered a novel mechanism by which AT2R promotes tumor development favoring both malignant cancer cell proliferation and tumor angiogenesis. Thus, blocking AT2R could be a new approach in tumor therapy.

The full text of this article is available in PDF format.
The full text of this article is available in PDF format.
Click here to see it.

Top of the page

© 2009  Elsevier Masson SAS. All Rights Reserved.
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Article Outline
You can move this window by clicking on the headline